COVID-19 Impact on In-vitro Diagnostic Services Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on In-vitro Diagnostic Services Industry
1.7 COVID-19 Impact: In-vitro Diagnostic Services Market Trends
2 Global In-vitro Diagnostic Services Quarterly Market Size Analysis
2.1 In-vitro Diagnostic Services Business Impact Assessment - COVID-19
2.1.1 Global In-vitro Diagnostic Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global In-vitro Diagnostic Services Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global In-vitro Diagnostic Services Quarterly Market Size, 2019 VS 2020
3.2 By Players, In-vitro Diagnostic Services Headquarters and Area Served
3.3 Date of Key Players Enter into In-vitro Diagnostic Services Market
3.4 Key Players In-vitro Diagnostic Services Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on In-vitro Diagnostic Services Segments, By Type
4.1 Introduction
1.4.1 Infectious Testing
1.4.2 Diabetes Testing
1.4.3 Molecular Testing
1.4.4 Tissue Testing
4.2 By Type, Global In-vitro Diagnostic Services Market Size, 2019-2021
5 Impact of Covid-19 on In-vitro Diagnostic Services Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Point-Of-Care Testing
5.5.3 Laboratories
5.5.4 Academic Institutes
5.2 By Application, Global In-vitro Diagnostic Services Market Size, 2019-2021
5.2.1 By Application, Global In-vitro Diagnostic Services Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 BioRad
7.1.1 BioRad Business Overview
7.1.2 BioRad In-vitro Diagnostic Services Quarterly Revenue, 2020
7.1.3 BioRad In-vitro Diagnostic Services Product Introduction
7.1.4 BioRad Response to COVID-19 and Related Developments
7.2 DexCom
7.2.1 DexCom Business Overview
7.2.2 DexCom In-vitro Diagnostic Services Quarterly Revenue, 2020
7.2.3 DexCom In-vitro Diagnostic Services Product Introduction
7.2.4 DexCom Response to COVID-19 and Related Developments
7.3 Nova Biomedical
7.3.1 Nova Biomedical Business Overview
7.3.2 Nova Biomedical In-vitro Diagnostic Services Quarterly Revenue, 2020
7.3.3 Nova Biomedical In-vitro Diagnostic Services Product Introduction
7.3.4 Nova Biomedical Response to COVID-19 and Related Developments
7.4 OraSure
7.4.1 OraSure Business Overview
7.4.2 OraSure In-vitro Diagnostic Services Quarterly Revenue, 2020
7.4.3 OraSure In-vitro Diagnostic Services Product Introduction
7.4.4 OraSure Response to COVID-19 and Related Developments
7.5 Pearl Pathways
7.5.1 Pearl Pathways Business Overview
7.5.2 Pearl Pathways In-vitro Diagnostic Services Quarterly Revenue, 2020
7.5.3 Pearl Pathways In-vitro Diagnostic Services Product Introduction
7.5.4 Pearl Pathways Response to COVID-19 and Related Developments
7.6 Phenomenex
7.6.1 Phenomenex Business Overview
7.6.2 Phenomenex In-vitro Diagnostic Services Quarterly Revenue, 2020
7.6.3 Phenomenex In-vitro Diagnostic Services Product Introduction
7.6.4 Phenomenex Response to COVID-19 and Related Developments
7.7 Qiagen
7.7.1 Qiagen Business Overview
7.7.2 Qiagen In-vitro Diagnostic Services Quarterly Revenue, 2020
7.7.3 Qiagen In-vitro Diagnostic Services Product Introduction
7.7.4 Qiagen Response to COVID-19 and Related Developments
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Business Overview
7.8.2 Roche Diagnostics In-vitro Diagnostic Services Quarterly Revenue, 2020
7.8.3 Roche Diagnostics In-vitro Diagnostic Services Product Introduction
7.8.4 Roche Diagnostics Response to COVID-19 and Related Developments
7.9 Siemens
7.9.1 Siemens Business Overview
7.9.2 Siemens In-vitro Diagnostic Services Quarterly Revenue, 2020
7.9.3 Siemens In-vitro Diagnostic Services Product Introduction
7.9.4 Siemens Response to COVID-19 and Related Developments
7.10 Sysmex
7.10.1 Sysmex Business Overview
7.10.2 Sysmex In-vitro Diagnostic Services Quarterly Revenue, 2020
7.10.3 Sysmex In-vitro Diagnostic Services Product Introduction
7.10.4 Sysmex Response to COVID-19 and Related Developments
7.11 Thermofisher
7.11.1 Thermofisher Business Overview
7.11.2 Thermofisher In-vitro Diagnostic Services Quarterly Revenue, 2020
7.11.3 Thermofisher In-vitro Diagnostic Services Product Introduction
7.11.4 Thermofisher Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on In-vitro Diagnostic Services Assessment
Table 9. COVID-19 Impact: In-vitro Diagnostic Services Market Trends
Table 10. COVID-19 Impact Global In-vitro Diagnostic Services Market Size
Table 11. Global In-vitro Diagnostic Services Quarterly Market Size, 2020 (US$ Million)
Table 12. Global In-vitro Diagnostic Services Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global In-vitro Diagnostic Services Market Growth Drivers
Table 14. Global In-vitro Diagnostic Services Market Restraints
Table 15. Global In-vitro Diagnostic Services Market Opportunities
Table 16. Global In-vitro Diagnostic Services Market Challenges
Table 17. By Players, In-vitro Diagnostic Services Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, In-vitro Diagnostic Services Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key In-vitro Diagnostic Services Players Headquarters and Area Served
Table 20. Date of Key Players Enter into In-vitro Diagnostic Services Market
Table 21. Key Players In-vitro Diagnostic Services Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global In-vitro Diagnostic Services Market Size 2019-2021, (US$ Million)
Table 24. Global In-vitro Diagnostic Services Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global In-vitro Diagnostic Services Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa In-vitro Diagnostic Services Market Size, 2019-2021 (US$ Million)
Table 57. BioRad Business Overview
Table 58. BioRad In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. BioRad In-vitro Diagnostic Services Product
Table 60. BioRad Response to COVID-19 and Related Developments
Table 61. DexCom Business Overview
Table 62. DexCom In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. DexCom In-vitro Diagnostic Services Product
Table 64. DexCom Response to COVID-19 and Related Developments
Table 65. Nova Biomedical Business Overview
Table 66. Nova Biomedical In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Nova Biomedical In-vitro Diagnostic Services Product
Table 68. Nova Biomedical Response to COVID-19 and Related Developments
Table 69. OraSure Business Overview
Table 70. OraSure In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. OraSure In-vitro Diagnostic Services Product
Table 72. OraSure Response to COVID-19 and Related Developments
Table 73. Pearl Pathways Business Overview
Table 74. Pearl Pathways In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Pearl Pathways In-vitro Diagnostic Services Product
Table 76. Pearl Pathways Response to COVID-19 and Related Developments
Table 77. Phenomenex Business Overview
Table 78. Phenomenex In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Phenomenex In-vitro Diagnostic Services Product
Table 80. Phenomenex Response to COVID-19 and Related Developments
Table 81. Qiagen Business Overview
Table 82. Qiagen In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Qiagen In-vitro Diagnostic Services Product
Table 84. Qiagen Response to COVID-19 and Related Developments
Table 85. Roche Diagnostics Business Overview
Table 86. Roche Diagnostics In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Roche Diagnostics In-vitro Diagnostic Services Product
Table 88. Roche Diagnostics Response to COVID-19 and Related Developments
Table 89. Siemens Business Overview
Table 90. Siemens In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Siemens In-vitro Diagnostic Services Product
Table 92. Siemens Response to COVID-19 and Related Developments
Table 93. Sysmex Business Overview
Table 94. Sysmex In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sysmex In-vitro Diagnostic Services Product
Table 96. Sysmex Response to COVID-19 and Related Developments
Table 97. Thermofisher Business Overview
Table 98. Thermofisher In-vitro Diagnostic Services Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Thermofisher In-vitro Diagnostic Services Product
Table 100. Thermofisher Response to COVID-19 and Related Developments
List of FiguresFigure 1. In-vitro Diagnostic Services Product Picture
Figure 2. In-vitro Diagnostic Services Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global In-vitro Diagnostic Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global In-vitro Diagnostic Services Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global In-vitro Diagnostic Services Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global In-vitro Diagnostic Services Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global In-vitro Diagnostic Services Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global In-vitro Diagnostic Services Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific In-vitro Diagnostic Services Market Size Market Share, 2019-2021